Cargando…

Common germline-somatic variant interactions in advanced urothelial cancer

The prevalence and biological consequences of deleterious germline variants in urothelial cancer (UC) are not fully characterized. We performed whole-exome sequencing (WES) of germline DNA and 157 primary and metastatic tumors from 80 UC patients. We developed a computational framework for identifyi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vosoughi, Aram, Zhang, Tuo, Shohdy, Kyrillus S., Vlachostergios, Panagiotis J., Wilkes, David C., Bhinder, Bhavneet, Tagawa, Scott T., Nanus, David M., Molina, Ana M., Beltran, Himisha, Sternberg, Cora N., Motanagh, Samaneh, Robinson, Brian D., Xiang, Jenny, Fan, Xiao, Chung, Wendy K., Rubin, Mark A., Elemento, Olivier, Sboner, Andrea, Mosquera, Juan Miguel, Faltas, Bishoy M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713129/ https://www.ncbi.nlm.nih.gov/pubmed/33273457 http://dx.doi.org/10.1038/s41467-020-19971-8

Ejemplares similares

Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling
por: Robinson, Brian D., et al.
Publicado: (2019)

Functional comparison of exome capture-based methods for transcriptomic profiling of formalin-fixed paraffin-embedded tumors
por: Shohdy, Kyrillus S., et al.
Publicado: (2021)

The genomic landscape of metastatic clear cell renal cell carcinoma after systemic therapy
por: van der Mijn, Johannes C., et al.
Publicado: (2022)

Integration of whole-exome and anchored PCR-based next generation sequencing significantly increases detection of actionable alterations in precision oncology
por: Beg, Shaham, et al.
Publicado: (2020)

Tumor-immune microenvironment revealed by Imaging Mass Cytometry in a metastatic sarcomatoid urothelial carcinoma with a prolonged response to pembrolizumab
por: Alnajar, Hussein, et al.
Publicado: (2022)

Whole-genome characterization of myoepithelial carcinomas of the soft tissue
por: Cyrta, Joanna, et al.
Publicado: (2022)

Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer care
por: Rennert, Hanna, et al.
Publicado: (2016)

Identification of a therapeutic target using molecular sequencing for treatment of recurrent uterine serous adenocarcinoma
por: Musselman, Kelsey, et al.
Publicado: (2019)

Trimodality therapy in variant urothelial carcinoma: choose wisely
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2017)

Validation of a Circulating Tumor DNA‐Based Next‐Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma Testing
por: Al Zoughbi, Wael, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors and Long-term Survival of Patients With Metastatic Urothelial Cancer
por: Zhu, Alec, et al.
Publicado: (2023)

Alopecia Universalis Associated with Ulcerative Colitis and The Role of Azathioprine
por: Shohdy, Kyrillus S, et al.
Publicado: (2018)

Circulating tumor cells in the cerebrospinal fluid: “tapping” into diagnostic and predictive potential
por: Faltas, Bishoy
Publicado: (2011)

Cornering metastases: therapeutic targeting of circulating tumor cells and stem cells
por: Faltas, Bishoy
Publicado: (2012)

Divergent clonal evolution of castration resistant neuroendocrine prostate cancer
por: Beltran, Himisha, et al.
Publicado: (2016)

Predicting peptide presentation by major histocompatibility complex class I: an improved machine learning approach to the immunopeptidome
por: Boehm, Kevin Michael, et al.
Publicado: (2019)

Lymphodepleting chemotherapy practices and effect on safety and efficacy outcomes in patients with solid tumours undergoing T cell receptor-engineered T cell (TCR-T) Therapy: a systematic review and meta-analysis
por: Owen, Kathryn, et al.
Publicado: (2022)

Is the Fixed-Dose Intravenous Trastuzumab Policy Warranted in Limited-Resource Settings?
por: Kassem, Loay, et al.
Publicado: (2019)

Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer
por: Brady, Nicholas J., et al.
Publicado: (2021)

Availability of Informal Caregivers for Palliative Care Patients with Cancer: Is there a Difference between Higher- and Lower-Income Settings
por: Abdel-Malek, Raafat, et al.
Publicado: (2019)

Prognostic Impact of Cytotoxic CD4 T Cells in Tumor Immune Microenvironment of Patients with Breast Cancer
por: Shohdy, Kyrillus S., et al.
Publicado: (2021)

Patient derived organoids to model rare prostate cancer phenotypes
por: Puca, Loredana, et al.
Publicado: (2018)

Molecular Evaluation of Low-grade Low-stage Endometrial Cancer With and Without Recurrence
por: Matrai, Cathleen E., et al.
Publicado: (2022)

Androgen receptor variant shows heterogeneous expression in prostate cancer according to differentiation stage
por: Gjyrezi, Ada, et al.
Publicado: (2021)

Demographic and genetic factors influence the abundance of infiltrating immune cells in human tissues
por: Marderstein, Andrew R., et al.
Publicado: (2020)

Epithelial plasticity can generate multi-lineage phenotypes in human and murine bladder cancers
por: Sfakianos, John P., et al.
Publicado: (2020)

Case report: Metastatic urothelial cancer with an exceptional response to immunotherapy and comprehensive understanding of the tumor and the tumor microenvironment
por: Sternberg, Cora N., et al.
Publicado: (2022)

Evidence of clinical efficacy of a first generation CD19 CAR T cell in B cell malignancies
por: Shohdy, Kyrillus S., et al.
Publicado: (2023)

Global evolution of the tumor microenvironment associated with progression from preinvasive invasive to invasive human lung adenocarcinoma
por: Altorki, Nasser K., et al.
Publicado: (2022)

Durable Response of Androgen Receptor-Positive Male Breast Cancer to Goserelin
por: Abdel Azim, Hamdy, et al.
Publicado: (2018)

The interplay of cell cycle and DNA repair gene alterations in upper tract urothelial carcinoma: predictive and prognostic implications
por: Vlachostergios, Panagiotis J
Publicado: (2020)

Prostate-Specific Membrane Antigen Uptake and Survival in Metastatic Castration-Resistant Prostate Cancer
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2021)

Randomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks (SHORTER)
por: Marciscano, Ariel E., et al.
Publicado: (2023)

Evolution of structural rearrangements in prostate cancer intracranial metastases
por: Khani, Francesca, et al.
Publicado: (2023)

Author Correction: Evolution of structural rearrangements in prostate cancer intracranial metastases
por: Khani, Francesca, et al.
Publicado: (2023)

Discovery of a Dicer-Independent, Cell-Type Dependent Alternate Targeting Sequence Generator: Implications in Gene Silencing & Pooled RNAi Screens
por: Bhinder, Bhavneet, et al.
Publicado: (2014)

ERG induces taxane resistance in castration-resistant prostate cancer
por: Galletti, Giuseppe, et al.
Publicado: (2014)

Causes of Death Among Patients With Metastatic Prostate Cancer in the US From 2000 to 2016
por: Elmehrath, Ahmed O., et al.
Publicado: (2021)

DNA Repair Gene Polymorphisms and Susceptibility to Urothelial Carcinoma in a Southeastern European Population
por: Samara, Maria, et al.
Publicado: (2021)

Cohesin Core Complex Gene Dosage Contributes to Germinal Center Derived Lymphoma Phenotypes and Outcomes
por: Rivas, Martin A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v9tn0pqoqddua0tij5ivjp4i5l